Merkel cell carcinoma is a rare cutaneous neuroendocrine carcinoma with a high rate of regional and distant metastasis and mortality. Here, we report a novel case of Merkel cell carcinoma which presented as a primary lesion to the left cheek with regional lymph node involvement and was treated with pembrolizumab and radiation. Widely metastatic disease eventually revealed on autopsy clinically mimicked immune-related organ insult leading to management with immunosuppressants. The patient also had a biopsy-confirmed immune-related cutaneous adverse event during admission. The case highlights a rare circumstance in which disease progression masqueraded as multiple immune-related end-organ adverse events. Contribution of on-target anti-PD-1 toxicity remains a possibility.
CITATION STYLE
Saqlain, F., Shalhout, S. Z., Emerick, K. S., Neilan, T. G., Sharova, T., & Miller, D. M. (2020). Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events. Case Reports in Dermatological Medicine, 2020. https://doi.org/10.1155/2020/8890845
Mendeley helps you to discover research relevant for your work.